Emre Kahraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emre Kahraman has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dursun Turkmen
Faculty of Medicine, Department of Dermatology, Inonu University
2 shared publications - Abdurrahim Bakırhan
Department of Psychiatry Faculty of Medicine İnönü University Malatya Türkiye
1 shared publication - Mehmet Enes Güner
Faculty of Medicine, Department of Dermatology, Inonu University
1 shared publication - Nihal Altunisik
Department of Dermatology, Inonu University Faculty of Medicine
1 shared publication - Rafet Ozbey
Department of Plastic, Reconstructive and Aesthetic Surgery, Inönü University Faculty of Medicine
1 shared publication - Samet Alagöz
Department of Dermatology, Inonu University Faculty of Medicine, Malatya, Turkiye
1 shared publication
Latest Publications
- Open Access
- 5 September 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Anxiety and Depression in Patients with Vitiligo: A Cross-Sectional Comparative Study
Vitiligo is a chronic depigmenting skin disorder that may adversely affect patients' psychosocial well-being because of its visible clinical manifestations. Anxiety and depression have been frequently investigated in patients with vitiligo; however, findings remain inconsistent across different populations. This study aimed to compare anxiety and depression levels between patients with vitiligo and healthy controls. This cross-sectional case–control study included 81 participants comprising 38 patients with vitiligo and 43 age-matched healthy controls. Sociodemographic data were collected using a structured questionnaire. Anxiety and depression were assessed using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). Normality was evaluated using the Shapiro–Wilk test. Since continuous variables were not normally distributed, between-group comparisons were performed using the Mann–Whitney U test, while categorical variables were compared using the chi-square test. Statistical significance was defined as p < 0.05. The mean age was 30.05 ± 8.85 years in the vitiligo group and 28.70 ± 7.67 years in the control group (p = 0.528). Female participants accounted for 73.7% of the vitiligo group and 58.1% of the control group (p = 0.217). Median anxiety and depression scores were comparable between groups. Mean anxiety scores were 13.32 ± 10.81 in the vitiligo group and 14.12 ± 11.54 in controls (p = 0.642). Mean depression scores were 13.82 ± 9.55 and 12.00 ± 11.32, respectively (p = 0.149). No statistically significant differences were detected between groups for any psychological outcome. Patients with vitiligo demonstrated anxiety and depression scores comparable to those of healthy controls. Although depression scores were numerically higher in the vitiligo group, the difference was not statistically significant. Larger multicenter studies incorporating disease severity and lesion localization are warranted to further clarify the psychological burden associated with vitiligo.
- 5 September 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Open AccessAnxiety and Depression in Patients with Vitiligo: A Cross-Sectional Comparative Study
Vitiligo is a chronic depigmenting skin disorder that may adversely affect patients' psychosocial well-being because of its visible clinical manifestations. Anxiety and depression have been frequently investigated in patients with vitiligo; however, findings remain inconsistent across different populations. This study aimed to compare anxiety and depression levels between patients with vitiligo and healthy controls. This cross-sectional case–control study included 81 participants comprising 38 patients with vitiligo and 43 age-matched healthy controls. Sociodemographic data were collected using a structured questionnaire. Anxiety and depression were assessed using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). Normality was evaluated using the Shapiro–Wilk test. Since continuous variables were not normally distributed, between-group comparisons were performed using the Mann–Whitney U test, while categorical variables were compared using the chi-square test. Statistical significance was defined as p < 0.05. The mean age was 30.05 ± 8.85 years in the vitiligo group and 28.70 ± 7.67 years in the control group (p = 0.528). Female participants accounted for 73.7% of the vitiligo group and 58.1% of the control group (p = 0.217). Median anxiety and depression scores were comparable between groups. Mean anxiety scores were 13.32 ± 10.81 in the vitiligo group and 14.12 ± 11.54 in controls (p = 0.642). Mean depression scores were 13.82 ± 9.55 and 12.00 ± 11.32, respectively (p = 0.149). No statistically significant differences were detected between groups for any psychological outcome. Patients with vitiligo demonstrated anxiety and depression scores comparable to those of healthy controls. Although depression scores were numerically higher in the vitiligo group, the difference was not statistically significant. Larger multicenter studies incorporating disease severity and lesion localization are warranted to further clarify the psychological burden associated with vitiligo.
- 28 August 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-8
In-hospital outcomes of SJS/TEN cases in a tertiary center: a 15-year cohort study
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe mucocutaneous adverse drug reactions associated with significant acute mortality and long-term sequelae. Alth...
- 28 August 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-8
In-hospital outcomes of SJS/TEN cases in a tertiary center: a 15-year cohort study
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe mucocutaneous adverse drug reactions associated with significant acute mortality and long-term sequelae. Alth...